Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Christie J, White MW, Wil... |
A chromatographic method for the detection of LSD in biological 1iquid... |
J.Chromatog. |
1976 |
Saito H, Kitagawa H |
Mechanisms of the reversal of blood pressure by ephedrine |
Jap.J.Pharmacol. |
1976 |
Stolaroff MJ, Wells CW |
Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 |
Yearbook for Ethnome... |
1993 |
Logan AS, Stickle B, O'Ke... |
Survival following 'Ecstasy' ingestion with a peak temperature of 42 d... |
Anaesthesia |
1993 |
Nash JF, Roth BL, Brodkin... |
Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl in... |
Neurosci Lett |
1994 |
Aulakh CS, Mazzola-Pomiet... |
Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced ... |
J Pharmacol Exp Ther |
1994 |
Aulakh CS, Mazzola-Pomiet... |
Role of various 5-HT receptor subtypes in mediating neuroendocrine eff... |
J Pharmacol Exp Ther |
1994 |
Nichols DE, Frescas S, Ma... |
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent s... |
J Med Chem |
1994 |
Hiratsuka A, Chu TY, Dist... |
Inactivation of constitutive hepatic cytochromes P450 by phencyclidine... |
Drug Metab Dispos |
1995 |
Yamamoto BK, Nash JF, Gud... |
Modulation of methylenedioxymethamphetamine-induced striatal dopamine ... |
J Pharmacol Exp Ther |
1995 |
Watanabe K, Matsunaga T, ... |
Involvement of CYP2C in the metabolism of cannabinoids by human hepati... |
Biol Pharm Bull |
1995 |
Aulakh CS, Mazzola-Pomiet... |
Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP sug... |
Neuropsychopharmacol... |
1995 |
Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
Padich RA, McCloskey TC, ... |
5-HT modulation of auditory and visual sensorimotor gating: II. Effect... |
Psychopharmacology (... |
1996 |
Monte AP, Marona-Lewicka ... |
Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substitut... |
J Med Chem |
1996 |
Benjamin J, Greenberg BD,... |
Daily administration of m-chlorophenylpiperazine to healthy human volu... |
Psychopharmacology B... |
1996 |
Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
Kramer HK, Poblete JC, Az... |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... |
Neuropsychopharmacol... |
1997 |
Yau JL, Noble J, Seckl JR |
Site-specific regulation of corticosteroid and serotonin receptor subt... |
Neuroscience |
1997 |
Monte AP, Waldman SR, Mar... |
Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives |
J Med Chem |
1997 |
Rodriquez B, de la Torre ... |
Neoclerodane Diterpenoids from Scutellaria pontica |
Journal of Natural P... |
1997 |
Rodriquez B, de la Torre ... |
Neoclerodane Diterpenoids from Scutellaria pontica |
Journal of Natural P... |
1997 |
Kramer HK, Poblete JC, Az... |
Characterization of the translocation of protein kinase C (PKC) by 3,4... |
Neuropsychopharmacol... |
1998 |
Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
Farber NB, Hanslick J, Ki... |
Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... |
Neuropsychopharmacol... |
1998 |
Grella B, Dukat M, Young ... |
Investigation of hallucinogenic and related beta-carbolines |
Drug Alcohol Depend |
1998 |
Donnelly-Roberts DL, Putt... |
ABT-594 [R-5-2-azetidinylmethoxy-2-chloropyridine]: a novel, orally ef... |
J Pharmacol Exp Ther |
1998 |
Krebs-Thomson K, Paulus M... |
Effects of hallucinogens on locomotor and investigatory activity and p... |
Neuropsychopharmacol... |
1998 |
Monte AP, Marona-Lewicka ... |
Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hy... |
J Med Chem |
1998 |
Rotzinger S, Fang J, Bake... |
Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from hu... |
Drug Metab Dispos |
1998 |
Giroud C, Augsburger M, R... |
2C-B: a new psychoactive phenylethylamine recently discovered in Ecsta... |
J Anal Toxicol |
1998 |
Smith RL, Canton H, Barre... |
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5... |
Pharmacol Biochem Be... |
1998 |
Vangveravong S, Kanthasam... |
Synthesis and serotonin receptor affinities of a series of trans-2-(in... |
J Med Chem |
1998 |
de la Torre R, Ortuno J, ... |
Fatal MDMA intoxication |
Lancet |
1999 |
Lavelle A, Honner V, Doch... |
Investigation of the prejunctional alpha2-adrenoceptor mediated action... |
Br J Pharmacol |
1999 |
Blair JB, Marona-Lewicka ... |
Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the ... |
J Med Chem |
1999 |
Giroud et al |
More Data About the New Psychoactive Drug 2C-B |
Journal of Analytica... |
1999 |
Blair, J.B., Marona-lewic... |
Thieno [3,2-b]- and Thieno[2,3-b] pyrrole Bioisosteric Analogues of th... |
Journal of Medicinal... |
1999 |
Whiteside M |
Synthesis of Hexahydrobenzodipyrans as Ring-Expanded Analogues of Pote... |
UW-La Crosse JUR |
1999 |
Arvanov VL, Liang X, Russ... |
LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... |
Eur J Neurosci |
1999 |
Bell SEJ, Burns DT, Denni... |
Rapid Analysis of Ecstasy and Related Phenethylamines in Seized Tablet... |
Analyst |
2000 |
Lauterbach EC, Abdelhamid... |
Posthallucinogen-like visual illusions (palinopsia) with risperidone i... |
Pharmacopsychiatry |
2000 |
Acuña-Castillo, C. Scorza... |
ALEPH-2, a suspected anxiolytic and putativehallucinogenic phenylisopr... |
Life Sciences |
2000 |
Dulawa SC, Geyer MA |
Effects of strain and serotonergic agents on prepulse inhibition and h... |
Neuropharmacology |
2000 |
Robertson P, DeCory HH, M... |
In vitro inhibition and induction of human hepatic cytochrome P450 enz... |
Drug Metab Dispos |
2000 |
Leone M, Attanasio A, Cro... |
The serotonergic agent m-chlorophenylpiperazine induces migraine attac... |
Neurology |
2000 |
Dowd CS, Herrick-Davis K,... |
1-[4-3-Phenylalkylphenyl]-2-aminopropanes as 5-HT2A partial agonists |
J Med Chem |
2000 |
Blair JB, Kurrasch-Orbaug... |
Effect of ring fluorination on the pharmacology of hallucinogenic tryp... |
J Med Chem |
2000 |
Vaiva G, Boss V, Bailly D... |
An 'Accidental' Acute Psychosis with Ecstasy Use |
J Psychoactive Drugs |
2001 |
Chambers JJ, Kurrasch-Orb... |
Enantiospecific synthesis and pharmacological evaluation of a series o... |
J Med Chem |
2001 |
Rajamani K, Leong S, Lave... |
Prejunctional actions of methylenedioxymethamphetamine in vas deferens... |
European Journal of ... |
2001 |
Yanagihara Y, Kariya S, O... |
Involvement of CYP2B6 in n-demethylation of ketamine in human liver mi... |
Drug Metab Dispos |
2001 |
Bankson MG, Cunningham KA |
Pharmacological Studies of the Acute Effects of (+)-3,4- Methylenediox... |
Neuropsychopharmacol... |
2002 |
Mechan AO, Esteban B, O'S... |
The pharmacology of the acute hyperthermic response that follows admin... |
Br J Pharmacol |
2002 |
Fletcher PJ, Korth KM, Ro... |
Multiple 5-HT receptors are involved in the effects of acute MDMA trea... |
Psychopharmacology (... |
2002 |
Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
Acuna-Castillo C, Villalo... |
Differences in potency and efficacy of a series of phenylisopropylamin... |
Br J Pharmacol |
2002 |
Chambers JJ, Kurrasch-Orb... |
Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamin... |
Bioorg Med Chem Lett |
2002 |
Riba J, Rodriguez-Fornel... |
Effects of ayahuasca on sensory and sensorimotor gating in humans as m... |
Psychopharmacology (... |
2002 |
Bull EJ, Hutson PH, Fone ... |
Reduced social interaction following 3,4-methylenedioxymethamphetamine... |
Neuropharmacology |
2003 |
McGregor IS, Clemens KJ, ... |
Increased Anxiety 3 Months after Brief Exposure to MDMA ('Ecstasy') in... |
Neuropsychopharmacol... |
2003 |
Wang JS, DeVane CL |
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- an... |
Drug Metab Dispos |
2003 |
Eckler JR, Chang-Fong J, ... |
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabol... |
Pharmacol Biochem Be... |
2003 |
Chambers JJ, Parrish JC, ... |
Synthesis and pharmacological characterization of a series of geometri... |
J Med Chem |
2003 |
Taffe MA, Huitron-Resendi... |
MDMA exposure alters cognitive and electrophysiological sensitivity to... |
Pharmacol Biochem Be... |
2003 |
Curtis B, Kemp P, Harty L... |
Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propyl... |
J Anal Toxicol |
2003 |
Curtis B, Kemp P, Harty L... |
Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propyl... |
J Anal Toxicol |
2003 |
Khorana N, Pullagurla MR,... |
Stimulus effects of three sulfur-containing psychoactive agents |
Pharmacology, Bioche... |
2004 |
Amstrong BD, Paik E, Chhi... |
POTENTIATION OF @L)-3,4=METHYLENEDIOXYMETHAMPHETAMINE (MDMA)-INDUCED T... |
Neuroscience Researc... |
2004 |
Feuchtl A, Bagli M, Steph... |
Pharmacokinetics of m-chlorophenylpiperazine after intravenous and ora... |
Pharmacopsychiatry |
2004 |
Vorce SP, Sklerov JH |
A general screening and confirmation approach to the analysis of desig... |
J Anal Toxicol |
2004 |
Carmo H, de Boer D, Remiã... |
Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine 2C... |
J Chromatogr B Analy... |
2004 |
Chiu YC, Chou SH, Liu JT,... |
The bioactivity of 2,5-dimethoxy-4-ethylthiophenethylamine 2C-T-2 and ... |
J Chromatogr B Analy... |
2004 |
Carmo H, Hengstler JG, de... |
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine 2C-B: analys... |
Toxicology |
2005 |
Theobald DS, Staack RF, P... |
New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-... |
J Mass Spectrom |
2005 |
Gresch PJ, Smith RL, Barr... |
Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with ... |
Neuropsychopharmacol... |
2005 |
Fantegrossi WE, Harringto... |
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylam... |
Psychopharmacology (... |
2005 |
Fantegrossi WE, Harringto... |
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylam... |
Psychopharmacology (... |
2005 |
Sard H, Kumaran G, Morenc... |
SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist |
Bioorg Med Chem Lett |
2005 |
Schifano F, Deluca P, Ago... |
New trends in the cyber and street market of recreational drugs? The c... |
J Psychopharmacol |
2005 |
Schifano F, Deluca P, Ago... |
New trends in the cyber and street market of recreational drugs? The c... |
J Psychopharmacol |
2005 |
Fantegrossi WE, Harringto... |
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mi... |
Pharmacol Biochem Be... |
2006 |
Cavallo F, Nencini C, Cap... |
In vitro binding studies of methanolic extracts from different salvia ... |
Pharmacolgyonline |
2006 |
McLean TH, Parrish JC, Br... |
1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinog... |
J Med Chem |
2006 |
Moreno FA, Wiegand CB, Ta... |
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients with Ob... |
J Clin Psychiatry |
2006 |
Braden MR, Parrish JC, Na... |
Molecular interaction of serotonin 5-HT2A receptor residues Phe339(651... |
Mol Pharmacol |
2006 |
Theobald DS, Maurer HH |
Identification of monoamine oxidase and cytochrome P450 isoenzymes inv... |
Biochem Pharmacol |
2007 |
Theobald DS, Fritschi G, ... |
Studies on the toxicological detection of the designer drug 4-bromo-2,... |
J Chromatogr B Analy... |
2007 |
Benneyworth MA, Xiang Z, ... |
A selective positive allosteric modulator of metabotropic glutamate re... |
Mol Pharmacol |
2007 |
Nonaka R, Nagai F, Ogata ... |
In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding i... |
Biol Pharm Bull |
2007 |
Pichini S, Pujadas M, Mar... |
Liquid chromatography-atmospheric pressure ionization electrospray mas... |
J Pharm Biomed Anal |
2008 |
Marona-Lewicka D, Chemel ... |
Dopamine D(4) receptor involvement in the discriminative stimulus effe... |
Psychopharmacology (... |
2008 |
Shioda K, Nisijima K, Yos... |
Risperidone attenuates and reverses hyperthermia induced by 3,4-methyl... |
Neurotoxicology |
2008 |
Marona-Lewicka D, Chemel ... |
Dopamine D(4) receptor involvement in the discriminative stimulus effe... |
Psychopharmacology (... |
2009 |
Drees JC, Stone JA, Wu AH |
Morbidity involving the hallucinogenic designer amines MDA and 2C-I |
J Forensic Sci |
2009 |
Ambrose JB, Bennett HD, L... |
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... |
Neurologist |
2010 |
Lindigkeit R, Böhme A, Ei... |
Synthese, Charakterisierung und Analyse von JWH-018-StrukturanalogenSy... |
|
2010 |
Meyer MR, Maurer HH |
Metabolism of designer drugs of abuse: an updated review |
Curr Drug Metab |
2010 |
Kerrigan S, Banuelos S, P... |
Simultaneous Detection of Ten Psychedelic Phenethylamines in Urine by ... |
Journal of Analytica... |
2011 |
Kerrigan S, Mellon MB, Ba... |
Evaluation of Commercial Enzyme-Linked Immunosorbent Assays to Identif... |
Journal of Analytica... |
2011 |